CRISPR/CAS Targeted in vivo Genome Modification for Studying the Functional Role of Genomic Regulatory Elements in Health and Carcinogenesis
- Authors: Kuzmich A.I.1, Zinovyeva M.V.1, Potapov V.K.1, Kostina M.B.1, Sverdlov E.D.1
-
Affiliations:
- Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
- Issue: Vol 33, No 1 (2018)
- Pages: 1-7
- Section: Reviews
- URL: https://journal-vniispk.ru/0891-4168/article/view/178236
- DOI: https://doi.org/10.3103/S0891416818010081
- ID: 178236
Cite item
Abstract
One problem in the study of regulatory mechanisms in living systems is the difficulty in analysis of regulatory elements in their natural context. One promising way to solve this problem is direct in situ modification of regulatory element sequences. The new technology of gene modification based on the bacterial CRISPR/Cas system allows one to quickly and accurately modify any genomic fragment, in particular, in cells of an adult organism. This review considers principles of the CRISPR/Cas technology and its application to the study of regulatory elements, as well as the potential of using this technology in studies of regulatory systems in pancreas tumors.
About the authors
A. I. Kuzmich
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
Author for correspondence.
Email: akrubik@gmail.com
Russian Federation, Moscow, 117997
M. V. Zinovyeva
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
Email: akrubik@gmail.com
Russian Federation, Moscow, 117997
V. K. Potapov
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
Email: akrubik@gmail.com
Russian Federation, Moscow, 117997
M. B. Kostina
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
Email: akrubik@gmail.com
Russian Federation, Moscow, 117997
E. D. Sverdlov
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
Email: akrubik@gmail.com
Russian Federation, Moscow, 117997
Supplementary files
